Tinna Björk finished her industrial PhD from DTU and Novo Nordisk A/S in 2020, on mathematical modelling for digital therapeutics in type 2 diabetes treatment.
Currently she is the technical project leader of an IFD Grand Solutions project, ADAPT-T2D, a collaboration between industry, academia and health clinics.